J
Jennifer Levinson
Publications - 4
Citations - 721
Jennifer Levinson is an academic researcher. The author has contributed to research in topics: Guideline & Breast cancer. The author has an hindex of 4, co-authored 4 publications receiving 605 citations.
Papers
More filters
Journal ArticleDOI
Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Sharon H. Giordano,Sarah Temin,Jeffrey J. Kirshner,Sarat Chandarlapaty,Jennie R. Crews,Nancy E. Davidson,Francisco J. Esteva,Ana M. Gonzalez-Angulo,Ian E. Krop,Jennifer Levinson,Nan Lin,Shanu Modi,Debra A. Patt,Edith A. Perez,Jane Perlmutter,Naren Ramakrishna,Eric P. Winer +16 more
TL;DR: Her2-targeted therapy is recommended for patients with HER2-positive advanced breast cancer, except for those with clinical congestive heart failure or significantly compromised left ventricular ejection fraction, who should be evaluated on a case-by-case basis.
Journal ArticleDOI
Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Clinical Practice Guideline Update
Sharon H. Giordano,Sharon H. Giordano,Sarah Temin,Sarat Chandarlapaty,Jennie R. Crews,Francisco J. Esteva,Jeffrey J. Kirshner,Ian E. Krop,Jennifer Levinson,Nan Lin,Shanu Modi,Debra A. Patt,Jane Perlmutter,Naren Ramakrishna,Eric P. Winer,Nancy E. Davidson +15 more
TL;DR: Recommendations for practicing oncologists and others on systemic therapy for patients with human epidermal growth factor receptor 2 (HER2)-positive advanced breast cancer to 2018 are updated and no additional evidence was identified that would warrant a change to the 2014 recommendations.
Journal ArticleDOI
Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases: American Society of Clinical Oncology Clinical Practice Guideline
Naren Ramakrishna,Sarah Temin,Sarat Chandarlapaty,Jennie R. Crews,Nancy E. Davidson,Francisco J. Esteva,Sharon H. Giordano,Ana M. Gonzalez-Angulo,Jeffrey J. Kirshner,Ian E. Krop,Jennifer Levinson,Shanu Modi,Debra A. Patt,Edith A. Perez,Jane Perlmutter,Eric P. Winer,Nan Lin +16 more
TL;DR: Clinicians should not perform routine magnetic resonance imaging to screen for brain metastases, but rather should have a low threshold for MRI of the brain because of the high incidence of brain metastase among patients with HER2-positive advanced breast cancer.
Journal ArticleDOI
Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update.
Naren Ramakrishna,Sarah Temin,Sarat Chandarlapaty,Jennie R. Crews,Nancy E. Davidson,Francisco J. Esteva,Sharon H. Giordano,Jeffrey J. Kirshner,Ian E. Krop,Jennifer Levinson,Shanu Modi,Debra A. Patt,Jane Perlmutter,Eric P. Winer,Nan Lin +14 more
TL;DR: The formal expert consensus-based guideline recommendations for practicing oncologists and others on the management of brain metastases for patients with human epidermal growth factor receptor 2-positive advanced breast cancer to 2018 are updated.